Rani Therapeutics Holdings Inc Cash Flow-to-Debt Ratio
Rani Therapeutics Holdings Inc cash flow-to-debt ratio. Rani Therapeutics Holdings Inc (RANI) has a Cash Flow-to-Debt Ratio of -0.70x as of June 2026, meaning its operating cash flow of $-9.03 Million could theoretically repay -1% of its total liabilities ($12.86 Million) in one year. See RANI financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Rani Therapeutics Holdings Inc (2019–2025)
Cash flow-to-debt ratio of Rani Therapeutics Holdings Inc from 2019 to 2025. Historical debt coverage capacity for Rani Therapeutics Holdings Inc across 7 annual periods. Check how aggressively does Rani Therapeutics Holdings Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Rani Therapeutics Holdings Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Rani Therapeutics Holdings Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Rani Therapeutics Holdings Inc. For the full cash flow conversion analysis, see how efficiently does Rani Therapeutics Holdings Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.09x | $-18.71 Million | $17.11 Million | ▼ -2.1% |
| 2024 | -1.07x | $-35.50 Million | $33.14 Million | ▲ +32.1% |
| 2023 | -1.58x | $-51.24 Million | $32.47 Million | ▼ -15.4% |
| 2022 | -1.37x | $-46.52 Million | $34.02 Million | ▲ +88.8% |
| 2021 | -12.21x | $-32.24 Million | $2.64 Million | ▼ -15637.3% |
| 2020 | -0.08x | $-14.96 Million | $192.75 Million | ▲ +64.6% |
| 2019 | -0.22x | $-26.27 Million | $119.66 Million | — |